View ValuationK+S 향후 성장Future 기준 점검 3/6K+S (는) 각각 연간 127.5% 및 0.9% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 130.3% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 2.9% 로 예상됩니다.핵심 정보127.5%이익 성장률130.32%EPS 성장률Chemicals 이익 성장20.8%매출 성장률0.9%향후 자기자본이익률2.88%애널리스트 커버리지Good마지막 업데이트21 May 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • May 12K+S Aktiengesellschaft to Report Q1, 2027 Results on May 11, 2027K+S Aktiengesellschaft announced that they will report Q1, 2027 results on May 11, 2027공시 • Apr 03K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026, at 10:00 W. Europe Standard Time.공시 • Mar 17K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027공시 • Mar 13K+S Aktiengesellschaft announces Annual dividend, payable on May 15, 2026K+S Aktiengesellschaft announced Annual dividend of EUR 0.0700 per share payable on May 15, 2026, ex-date on May 13, 2026 and record date on May 14, 2026.공시 • Nov 17K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026공시 • Aug 15K+S Aktiengesellschaft to Report Q2, 2026 Results on Aug 12, 2026K+S Aktiengesellschaft announced that they will report Q2, 2026 results on Aug 12, 2026공시 • May 15K+S Aktiengesellschaft to Report Q1, 2026 Results on May 11, 2026K+S Aktiengesellschaft announced that they will report Q1, 2026 results on May 11, 2026공시 • Apr 03+ 1 more updateK+S Aktiengesellschaft, Annual General Meeting, May 14, 2025K+S Aktiengesellschaft, Annual General Meeting, May 14, 2025, at 10:00 W. Europe Standard Time.공시 • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2025 Results on Mar 12, 2026K+S Aktiengesellschaft announced that they will report fiscal year 2025 results on Mar 12, 2026공시 • Nov 15K+S Aktiengesellschaft to Report Q3, 2025 Results on Nov 11, 2025K+S Aktiengesellschaft announced that they will report Q3, 2025 results on Nov 11, 2025Reported Earnings • Nov 15Third quarter 2024 earnings released: €0.15 loss per share (vs €0.26 loss in 3Q 2023)Third quarter 2024 results: €0.15 loss per share (improved from €0.26 loss in 3Q 2023). Revenue: €866.2m (down 1.7% from 3Q 2023). Net loss: €26.4m (loss narrowed 45% from 3Q 2023). Revenue is forecast to stay flat during the next 3 years compared to a 4.4% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.공시 • Oct 24+ 1 more updateK+S Group Announces CFO Changes, Effective June 1, 2025K+S Group(SDFG) appointed Jens Christian Keuthen, currently Head of Legal, Tax, Regulatory Affairs, and New Business Areas at K+S, as CFO. Company appointed Chief Financial Officer Christian Meyer as the Chairman of the Board. All new appointments are effective from June 1, 2025.공시 • Aug 14K+S Aktiengesellschaft to Report Q2, 2025 Results on Aug 12, 2025K+S Aktiengesellschaft announced that they will report Q2, 2025 results on Aug 12, 2025공시 • May 14K+S Aktiengesellschaft to Report Q1, 2025 Results on May 13, 2025K+S Aktiengesellschaft announced that they will report Q1, 2025 results on May 13, 2025Reported Earnings • Mar 18Full year 2023 earnings released: EPS: €1.12 (vs €7.88 in FY 2022)Full year 2023 results: EPS: €1.12 (down from €7.88 in FY 2022). Revenue: €3.87b (down 32% from FY 2022). Net income: €209.9m (down 86% from FY 2022). Profit margin: 5.4% (down from 27% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 4.7% growth forecast for the Chemicals industry in Europe.공시 • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2024 Results on Mar 13, 2025K+S Aktiengesellschaft announced that they will report fiscal year 2024 results on Mar 13, 2025공시 • Nov 24+ 1 more updateK+S Aktiengesellschaft to Report Q3, 2024 Results on Nov 14, 2024K+S Aktiengesellschaft announced that they will report Q3, 2024 results at 7:00 AM, Central European Standard Time on Nov 14, 2024공시 • Aug 15K+S Aktiengesellschaft to Report Q1, 2024 Results on May 13, 2024K+S Aktiengesellschaft announced that they will report Q1, 2024 results at 7:00 AM, Central European Standard Time on May 13, 2024공시 • Aug 11K+S Aktiengesellschaft to Report Q2, 2024 Results on Aug 14, 2024K+S Aktiengesellschaft announced that they will report Q2, 2024 results on Aug 14, 2024공시 • Jan 27K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH).K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH) on January 26, 2023. The new business will operate under the name Fertiva (Pty) Ltd. The balance of 25% of shares in Fertiva will be held by two former ICH shareholders, who will now be a part of the Fertiva management team. The closing of the transaction remains subject to the fulfillment of a number of conditions, including obtaining required regulatory approvals and is expected to close during the second quarter of 2023.공시 • Jan 22K+S Aktiengesellschaft Appoints Carin-Martina Tröltzsch as Member of the Board of Executive Directors, Effective March 15, 2023The Supervisory Board of K+S Aktiengesellschaft has appointed Dr. Carin-Martina Tröltzsch as a further member of the Board of Executive Directors of the Company. She will assume her position at K+S on March 15, 2023. Dr. Christian H. Meyer, who was already appointed as the new Chief Financial Officer by the Supervisory Board of the Company in February of last year, will also take up his position on March 15, 2023, and will be responsible for the management and further development of the finance area at K+S. Dr. Burkhard Lohr, Chairman of the Board of Executive Directors, had assumed this role on a transitional basis in recent months.공시 • Nov 13K+S Aktiengesellschaft to Report Q3, 2022 Results on Nov 14, 2023K+S Aktiengesellschaft announced that they will report Q3, 2022 results at 7:00 AM, Central European Standard Time on Nov 14, 2023Reported Earnings • Aug 16Second quarter 2022 earnings released: EPS: €1.94 (vs €0.78 in 2Q 2021)Second quarter 2022 results: EPS: €1.94 (up from €0.78 in 2Q 2021). Revenue: €1.51b (up 127% from 2Q 2021). Net income: €370.3m (up 147% from 2Q 2021). Profit margin: 25% (up from 23% in 2Q 2021). Over the next year, revenue is forecast to grow 20%, compared to a 13% growth forecast for the Chemicals industry in Europe.공시 • Aug 12K+S Aktiengesellschaft to Report Q2, 2023 Results on Aug 10, 2023K+S Aktiengesellschaft announced that they will report Q2, 2023 results on Aug 10, 2023Reported Earnings • May 13First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €1.21b (up 65% from 1Q 2021). Net income: €310.9m (up 44% from 1Q 2021). Profit margin: 26% (down from 29% in 1Q 2021). Over the next year, revenue is forecast to grow 46%, compared to a 17% growth forecast for the industry in Europe.공시 • May 12K+S Aktiengesellschaft to Report Q1, 2023 Results on May 09, 2023K+S Aktiengesellschaft announced that they will report Q1, 2023 results on May 09, 2023Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improved over the past weekAfter last week's 18% share price gain to €34.40, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 14x in the Chemicals industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €34.82 per share.Buying Opportunity • Mar 29Now 24% undervaluedOver the last 90 days, the stock is up 68%. The fair value is estimated to be €33.58, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% per annum over the last 3 years. The company has become profitable over the last year.Valuation Update With 7 Day Price Move • Mar 23Investor sentiment improved over the past weekAfter last week's 19% share price gain to €28.61, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 15x in the Chemicals industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €33.96 per share.Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the industry in Europe.Buying Opportunity • Feb 11Now 21% undervaluedOver the last 90 days, the stock is up 34%. The fair value is estimated to be €24.77, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 24% per annum over the last 3 years. The company has become profitable over the last year.Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS €6.64 (vs €10.26 loss in 3Q 2020)Third quarter 2021 results: Revenue: €746.3m (down 9.2% from 3Q 2020). Net income: €1.27b (up €3.23b from 3Q 2020).Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS €0.78 (vs €0.019 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €664.2m (up 13% from 2Q 2020). Net income: €149.9m (up €153.6m from 2Q 2020). Profit margin: 23% (up from net loss in 2Q 2020). The move to profitability was primarily driven by lower expenses.이익 및 매출 성장 예측BUL:SDF - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20283,8111181356001012/31/20273,864169856071412/31/20263,8571253649113/31/20263,744-1,31872625N/A12/31/20253,648-1,07610573N/A9/30/20253,640-1,699-7524N/A6/30/20253,627-1,7281537N/A3/31/20253,6300-17528N/A12/31/20243,653-6769591N/A9/30/20243,70226122656N/A6/30/20243,7174153659N/A3/31/20243,669-35339828N/A12/31/20233,873210339821N/A9/30/20234,383715440908N/A6/30/20234,9721,0459521,388N/A3/31/20235,6561,4619251,356N/A12/31/20225,6771,5089181,392N/A9/30/20225,2621,4629671,385N/A6/30/20224,5382,450319742N/A3/31/20223,6922,22935433N/A12/31/20213,2132,134-32327N/A9/30/20212,7721,559-274183N/A6/30/20212,592-1,458-325175N/A3/31/20212,518-1,612-219321N/A12/31/20202,432-1,891-108429N/A9/30/20201,306-1,853-84458N/A6/30/20201,645-163-96445N/A3/31/20201,933-14554570N/A12/31/20192,55027N/A640N/A9/30/20194,264127N/A543N/A6/30/20194,199121N/A534N/A3/31/20194,13375N/A400N/A12/31/20184,03942N/A309N/A9/30/20183,85413N/A200N/A6/30/20183,74089N/A215N/A3/31/20183,670159N/A273N/A12/31/20173,627185N/A307N/A9/30/20173,536154N/A438N/A6/30/20173,497113N/A471N/A3/31/20173,48875N/A419N/A12/31/20163,457174N/A445N/A9/30/20163,508302N/A447N/A6/30/20163,712380N/A605N/A3/31/20163,894533N/A662N/A12/31/20154,176495N/A669N/A9/30/20154,203428N/A708N/A6/30/20154,139467N/A626N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: SDF 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(3.5%)보다 빠른 성장으로 간주됩니다.수익 vs 시장: SDF (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.고성장 수익: SDF 향후 3년 내에 수익을 낼 것으로 예상됩니다.수익 대 시장: SDF 의 수익(연간 0.9%)이 BG 시장(연간 5.3%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: SDF 의 수익(연간 0.9%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: SDF의 자본 수익률은 3년 후 2.9%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 17:12종가2026/03/02 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스K+S Aktiengesellschaft는 43명의 분석가가 다루고 있습니다. 이 중 14명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Stephen WilderAlliance Global PartnersKonstantin WiechertBaader Helvea Equity ResearchKnut WollerBaader Helvea Equity Research40명의 분석가 더 보기
공시 • May 12K+S Aktiengesellschaft to Report Q1, 2027 Results on May 11, 2027K+S Aktiengesellschaft announced that they will report Q1, 2027 results on May 11, 2027
공시 • Apr 03K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026, at 10:00 W. Europe Standard Time.
공시 • Mar 17K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027
공시 • Mar 13K+S Aktiengesellschaft announces Annual dividend, payable on May 15, 2026K+S Aktiengesellschaft announced Annual dividend of EUR 0.0700 per share payable on May 15, 2026, ex-date on May 13, 2026 and record date on May 14, 2026.
공시 • Nov 17K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026
공시 • Aug 15K+S Aktiengesellschaft to Report Q2, 2026 Results on Aug 12, 2026K+S Aktiengesellschaft announced that they will report Q2, 2026 results on Aug 12, 2026
공시 • May 15K+S Aktiengesellschaft to Report Q1, 2026 Results on May 11, 2026K+S Aktiengesellschaft announced that they will report Q1, 2026 results on May 11, 2026
공시 • Apr 03+ 1 more updateK+S Aktiengesellschaft, Annual General Meeting, May 14, 2025K+S Aktiengesellschaft, Annual General Meeting, May 14, 2025, at 10:00 W. Europe Standard Time.
공시 • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2025 Results on Mar 12, 2026K+S Aktiengesellschaft announced that they will report fiscal year 2025 results on Mar 12, 2026
공시 • Nov 15K+S Aktiengesellschaft to Report Q3, 2025 Results on Nov 11, 2025K+S Aktiengesellschaft announced that they will report Q3, 2025 results on Nov 11, 2025
Reported Earnings • Nov 15Third quarter 2024 earnings released: €0.15 loss per share (vs €0.26 loss in 3Q 2023)Third quarter 2024 results: €0.15 loss per share (improved from €0.26 loss in 3Q 2023). Revenue: €866.2m (down 1.7% from 3Q 2023). Net loss: €26.4m (loss narrowed 45% from 3Q 2023). Revenue is forecast to stay flat during the next 3 years compared to a 4.4% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.
공시 • Oct 24+ 1 more updateK+S Group Announces CFO Changes, Effective June 1, 2025K+S Group(SDFG) appointed Jens Christian Keuthen, currently Head of Legal, Tax, Regulatory Affairs, and New Business Areas at K+S, as CFO. Company appointed Chief Financial Officer Christian Meyer as the Chairman of the Board. All new appointments are effective from June 1, 2025.
공시 • Aug 14K+S Aktiengesellschaft to Report Q2, 2025 Results on Aug 12, 2025K+S Aktiengesellschaft announced that they will report Q2, 2025 results on Aug 12, 2025
공시 • May 14K+S Aktiengesellschaft to Report Q1, 2025 Results on May 13, 2025K+S Aktiengesellschaft announced that they will report Q1, 2025 results on May 13, 2025
Reported Earnings • Mar 18Full year 2023 earnings released: EPS: €1.12 (vs €7.88 in FY 2022)Full year 2023 results: EPS: €1.12 (down from €7.88 in FY 2022). Revenue: €3.87b (down 32% from FY 2022). Net income: €209.9m (down 86% from FY 2022). Profit margin: 5.4% (down from 27% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 4.7% growth forecast for the Chemicals industry in Europe.
공시 • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2024 Results on Mar 13, 2025K+S Aktiengesellschaft announced that they will report fiscal year 2024 results on Mar 13, 2025
공시 • Nov 24+ 1 more updateK+S Aktiengesellschaft to Report Q3, 2024 Results on Nov 14, 2024K+S Aktiengesellschaft announced that they will report Q3, 2024 results at 7:00 AM, Central European Standard Time on Nov 14, 2024
공시 • Aug 15K+S Aktiengesellschaft to Report Q1, 2024 Results on May 13, 2024K+S Aktiengesellschaft announced that they will report Q1, 2024 results at 7:00 AM, Central European Standard Time on May 13, 2024
공시 • Aug 11K+S Aktiengesellschaft to Report Q2, 2024 Results on Aug 14, 2024K+S Aktiengesellschaft announced that they will report Q2, 2024 results on Aug 14, 2024
공시 • Jan 27K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH).K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH) on January 26, 2023. The new business will operate under the name Fertiva (Pty) Ltd. The balance of 25% of shares in Fertiva will be held by two former ICH shareholders, who will now be a part of the Fertiva management team. The closing of the transaction remains subject to the fulfillment of a number of conditions, including obtaining required regulatory approvals and is expected to close during the second quarter of 2023.
공시 • Jan 22K+S Aktiengesellschaft Appoints Carin-Martina Tröltzsch as Member of the Board of Executive Directors, Effective March 15, 2023The Supervisory Board of K+S Aktiengesellschaft has appointed Dr. Carin-Martina Tröltzsch as a further member of the Board of Executive Directors of the Company. She will assume her position at K+S on March 15, 2023. Dr. Christian H. Meyer, who was already appointed as the new Chief Financial Officer by the Supervisory Board of the Company in February of last year, will also take up his position on March 15, 2023, and will be responsible for the management and further development of the finance area at K+S. Dr. Burkhard Lohr, Chairman of the Board of Executive Directors, had assumed this role on a transitional basis in recent months.
공시 • Nov 13K+S Aktiengesellschaft to Report Q3, 2022 Results on Nov 14, 2023K+S Aktiengesellschaft announced that they will report Q3, 2022 results at 7:00 AM, Central European Standard Time on Nov 14, 2023
Reported Earnings • Aug 16Second quarter 2022 earnings released: EPS: €1.94 (vs €0.78 in 2Q 2021)Second quarter 2022 results: EPS: €1.94 (up from €0.78 in 2Q 2021). Revenue: €1.51b (up 127% from 2Q 2021). Net income: €370.3m (up 147% from 2Q 2021). Profit margin: 25% (up from 23% in 2Q 2021). Over the next year, revenue is forecast to grow 20%, compared to a 13% growth forecast for the Chemicals industry in Europe.
공시 • Aug 12K+S Aktiengesellschaft to Report Q2, 2023 Results on Aug 10, 2023K+S Aktiengesellschaft announced that they will report Q2, 2023 results on Aug 10, 2023
Reported Earnings • May 13First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €1.21b (up 65% from 1Q 2021). Net income: €310.9m (up 44% from 1Q 2021). Profit margin: 26% (down from 29% in 1Q 2021). Over the next year, revenue is forecast to grow 46%, compared to a 17% growth forecast for the industry in Europe.
공시 • May 12K+S Aktiengesellschaft to Report Q1, 2023 Results on May 09, 2023K+S Aktiengesellschaft announced that they will report Q1, 2023 results on May 09, 2023
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improved over the past weekAfter last week's 18% share price gain to €34.40, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 14x in the Chemicals industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €34.82 per share.
Buying Opportunity • Mar 29Now 24% undervaluedOver the last 90 days, the stock is up 68%. The fair value is estimated to be €33.58, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% per annum over the last 3 years. The company has become profitable over the last year.
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment improved over the past weekAfter last week's 19% share price gain to €28.61, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 15x in the Chemicals industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €33.96 per share.
Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the industry in Europe.
Buying Opportunity • Feb 11Now 21% undervaluedOver the last 90 days, the stock is up 34%. The fair value is estimated to be €24.77, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 24% per annum over the last 3 years. The company has become profitable over the last year.
Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS €6.64 (vs €10.26 loss in 3Q 2020)Third quarter 2021 results: Revenue: €746.3m (down 9.2% from 3Q 2020). Net income: €1.27b (up €3.23b from 3Q 2020).
Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS €0.78 (vs €0.019 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €664.2m (up 13% from 2Q 2020). Net income: €149.9m (up €153.6m from 2Q 2020). Profit margin: 23% (up from net loss in 2Q 2020). The move to profitability was primarily driven by lower expenses.